Human medicines European public assessment report (EPAR): Ohtuvayre, ensifentrine, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Insulin Aspart Injection, insulin aspart, Status: Application withdrawn
Summary of opinion: Xerava, 13/11/2025 Positive
Human medicines European public assessment report (EPAR): Nurzigma, pridopidine, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Aqneursa, L-acetylleucine, Status: Opinion
Human medicines European public assessment report (EPAR): Enzalutamide Accordpharma, enzalutamide, Status: Opinion
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 November 2025
Human medicines European public assessment report (EPAR): Dawnzera, donidalorsen, Status: Opinion
Human medicines European public assessment report (EPAR): GalenVita, germanium (68Ge) chloride,gallium (68Ga) chloride, Status: Opinion
Human medicines European public assessment report (EPAR): Ondibta, insulin glargine, Status: Opinion